SG Americas Securities
NFH

SG Americas Securities’s New Frontier Health Corporation Ordinary Shares NFH Stock Holding History

SG Americas Securities’s Portfolio NFH Stock Details NFH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-19,741
Closed -$226K – 3662
2021
Q4 		$226K Buy
19,741
+1,473
+8% +$16.6K ﹤0.01% 2608
2021
Q3 		$205K Buy
+18,268
New +$204K ﹤0.01% 3224

Other funds holding NFH

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

SG Americas Securities's NFH Position: Q1 2022 in Review

SG Americas Securities sold out of New Frontier Health Corporation Ordinary Shares (NFH) in Q1 2022, closing a stake of 19,741 shares — an estimated $226K sold.

SG Americas Securities first reported a position in NFH in Q3 2021 and held it in 2 quarters. The position peaked at $226K in Q4 2021. 2 funds tracked by Wall St. Rank hold NFH as of Q1 2022.

  • SG Americas Securities reported no remaining New Frontier Health Corporation Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • SG Americas Securities sold 19,741 New Frontier Health Corporation Ordinary Shares shares in Q1 2022, an estimated $226K.
  • SG Americas Securities first reported a position in New Frontier Health Corporation Ordinary Shares in Q3 2021 and held it in 2 quarters.
  • SG Americas Securities's New Frontier Health Corporation Ordinary Shares position peaked at $226K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held New Frontier Health Corporation Ordinary Shares as of Q1 2022.

Based on SG Americas Securities's 13F filing for Q1 2022, filed 29 Apr 2022.